Cell Line : LB647-SCLC
Cellosaurus Index : CVCL_1368
Cellosaurus ID : LB647-SCLC
GDSC1 Name
, GDSC2 Name
: LB647-SCLC
CCLE Name
: LB647SCLC_LUNG
Cancer Type : lung
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| LB647-SCLC | (5Z)-7-Oxozeaenol | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | 5-Fluorouracil | GDSC1,GDSC2 | 0.0200 | 32.0000 |
|
| LB647-SCLC | A-443654 | GDSC1 | 0.0040 | 1.0240 |
|
| LB647-SCLC | A-770041 | GDSC1 | 0.0200 | 5.1200 |
|
| LB647-SCLC | A-83-01 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | ABT737 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | ACY-1215 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | Afatinib | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| LB647-SCLC | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | AGI-6780 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| LB647-SCLC | AGK-2 | GDSC2 | 0.0040 | 4.0000 |
|
| LB647-SCLC | AICA Ribonucleotide | GDSC1 | 7.8125 | 2000.0000 |
|
| LB647-SCLC | AKT inhibitor VIII | GDSC1 | 0.0100 | 10.2400 |
|
| LB647-SCLC | Alisertib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Alpelisib | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Apitolisib | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | AR-42 | GDSC1 | 0.0200 | 5.1200 |
|
| LB647-SCLC | Ara-G | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | ARRY-520 | GDSC1 | 0.0010 | 0.2560 |
|
| LB647-SCLC | AS601245 | GDSC1 | 0.0312 | 8.0000 |
|
| LB647-SCLC | AS605240 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | AST-1306 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | AT-7519 | GDSC1 | 0.0400 | 10.2400 |
|
| LB647-SCLC | AT13148 | GDSC2 | 0.0080 | 8.0000 |
|
| LB647-SCLC | AT7867 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Axitinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LB647-SCLC | AZ20 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | AZ628 | GDSC1 | 0.0156 | 4.0000 |
|
| LB647-SCLC | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | AZD1208 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | AZD1332 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | AZD1480 | GDSC1 | 0.0098 | 2.5000 |
|
| LB647-SCLC | AZD2014 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | AZD3514 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| LB647-SCLC | AZD4547 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | AZD4877 | GDSC1 | 0.0002 | 0.0390 |
|
| LB647-SCLC | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | AZD5438 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | AZD5582 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | AZD6094 | GDSC1 | 0.0098 | 2.5000 |
|
| LB647-SCLC | AZD6482 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | AZD6738 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | AZD7762 | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| LB647-SCLC | AZD7969 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | AZD8055 | GDSC1 | 0.0078 | 2.0000 |
|
| LB647-SCLC | AZD8186 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| LB647-SCLC | AZD8835 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | AZD8931 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | BAM7 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | BAY-61-3606 | GDSC1 | 0.0312 | 8.0000 |
|
| LB647-SCLC | Belinostat | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | Bexarotene | GDSC1 | 0.0312 | 8.0000 |
|
| LB647-SCLC | BI-2536 | GDSC1,GDSC2 | 0.0005 | 0.5000 |
|
| LB647-SCLC | BIBF-1120 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | BIBR-1532 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Bicalutamide | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| LB647-SCLC | Bleomycin | GDSC1 | 0.2500 | 64.0000 |
|
| LB647-SCLC | Bleomycin (10 uM) | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | Bleomycin (50 uM) | GDSC1 | 0.1953 | 50.0000 |
|
| LB647-SCLC | BMS-345541 | GDSC1,GDSC2 | 0.0100 | 16.0000 |
|
| LB647-SCLC | BMS-509744 | GDSC1 | 0.0400 | 10.2400 |
|
| LB647-SCLC | BMS-536924 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | BMS-754807 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Bortezomib | GDSC1,GDSC2 | 0.0000 | 0.0200 |
|
| LB647-SCLC | Bosutinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LB647-SCLC | BPTES | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | Brivanib, BMS-540215 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | Bryostatin 1 | GDSC1 | 0.0000 | 0.0080 |
|
| LB647-SCLC | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | BX-912 | GDSC1 | 0.0400 | 10.2400 |
|
| LB647-SCLC | BX795 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | C-75 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| LB647-SCLC | CAP-232, TT-232, TLN-232 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | Capivasertib | GDSC1 | 0.1172 | 30.0000 |
|
| LB647-SCLC | CAY10566 | GDSC1 | 0.0100 | 2.5600 |
|
| LB647-SCLC | CAY10603 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | CCT-018159 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | CCT007093 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | CCT245232 | GDSC1 | 0.0008 | 0.2000 |
|
| LB647-SCLC | CCT245467 | GDSC1 | 0.0008 | 0.2000 |
|
| LB647-SCLC | CD532 | GDSC1 | 0.0200 | 5.1200 |
|
| LB647-SCLC | Cediranib | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | CGP-082996 | GDSC1 | 0.0200 | 5.1200 |
|
| LB647-SCLC | CGP-60474 | GDSC1 | 0.0010 | 0.2560 |
|
| LB647-SCLC | CHIR-99021 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | CI-1033 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | CI-1040 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | Cisplatin | GDSC1 | 0.0117 | 6.0000 |
|
| LB647-SCLC | CMK | GDSC1 | 0.0156 | 4.0000 |
|
| LB647-SCLC | CP466722 | GDSC1 | 0.0625 | 16.0000 |
|
| LB647-SCLC | CPI-613 | GDSC1 | 1.0000 | 256.0000 |
|
| LB647-SCLC | Crizotinib | GDSC1,GDSC2 | 0.0040 | 8.0000 |
|
| LB647-SCLC | CRT0105446 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | CRT0105950 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | CRT0160829 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | CUDC-101 | GDSC1 | 0.0200 | 5.1200 |
|
| LB647-SCLC | CX-5461 | GDSC1 | 0.0400 | 10.2400 |
|
| LB647-SCLC | Cyclopamine | GDSC1 | 0.0625 | 16.0000 |
|
| LB647-SCLC | Cyclophosphamide | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Cytarabine | GDSC1 | 0.0078 | 2.0000 |
|
| LB647-SCLC | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Dabrafenib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Dacinostat | GDSC1 | 0.0040 | 1.0240 |
|
| LB647-SCLC | Dactinomycin | GDSC2 | 0.0008 | 0.8000 |
|
| LB647-SCLC | Dactolisib | GDSC1,GDSC2 | 0.0003 | 0.2500 |
|
| LB647-SCLC | Daporinad | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| LB647-SCLC | Dasatinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LB647-SCLC | Dinaciclib | GDSC2 | 0.0010 | 1.0000 |
|
| LB647-SCLC | DMOG | GDSC1 | 15.6250 | 4000.0000 |
|
| LB647-SCLC | Docetaxel | GDSC1,GDSC2 | 0.0000 | 0.0125 |
|
| LB647-SCLC | Doramapimod | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Doxorubicin | GDSC1 | 0.0040 | 5.0000 |
|
| LB647-SCLC | Dyrk1b_0191 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | eEF2K Inhibitor, A-484954 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | EHT-1864 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Elesclomol | GDSC1,GDSC2 | 0.0002 | 0.2000 |
|
| LB647-SCLC | Embelin | GDSC1 | 0.1250 | 32.0000 |
|
| LB647-SCLC | Entinostat | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Enzastaurin | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | EphB4_9721 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | Epirubicin | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Epothilone B | GDSC1 | 0.0001 | 0.0320 |
|
| LB647-SCLC | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Erlotinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LB647-SCLC | Etoposide | GDSC1 | 0.0625 | 16.0000 |
|
| LB647-SCLC | ETP-45835 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | FEN1_3940 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | FGFR_0939 | GDSC1 | 0.0098 | 2.5000 |
|
| LB647-SCLC | FGFR_3831 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | FH535 | GDSC1 | 0.1250 | 32.0000 |
|
| LB647-SCLC | Flavopiridol | GDSC1 | 0.0100 | 2.5600 |
|
| LB647-SCLC | FMK | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | Foretinib | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | FS106 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | FS112 | GDSC1 | 0.0195 | 5.0000 |
|
| LB647-SCLC | FTI-277 | GDSC1 | 0.0040 | 1.0240 |
|
| LB647-SCLC | FTY-720 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | Fulvestrant | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| LB647-SCLC | FY012 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | FY026 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | FY069 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Gefitinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LB647-SCLC | Gemcitabine | GDSC1,GDSC2 | 0.0002 | 10.0000 |
|
| LB647-SCLC | Genentech Cpd 10 | GDSC1 | 0.0400 | 10.2400 |
|
| LB647-SCLC | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | GNF-2 | GDSC1 | 0.0050 | 1.2800 |
|
| LB647-SCLC | GSK-J4 | GDSC1 | 0.1172 | 30.0000 |
|
| LB647-SCLC | GSK1059615 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | GSK1070916 | GDSC1 | 0.0100 | 2.5600 |
|
| LB647-SCLC | GSK1904529A | GDSC1,GDSC2 | 0.0040 | 5.0000 |
|
| LB647-SCLC | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | GSK269962A | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| LB647-SCLC | GSK319347A | GDSC1 | 0.0195 | 5.0000 |
|
| LB647-SCLC | GSK343 | GDSC2 | 0.0010 | 1.0000 |
|
| LB647-SCLC | GSK429286A | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | GSK650394 | GDSC1 | 0.0625 | 16.0000 |
|
| LB647-SCLC | GW441756 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LB647-SCLC | GW843682X | GDSC1 | 0.0010 | 0.2560 |
|
| LB647-SCLC | HG-5-113-01 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | HG-5-88-01 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | HG-6-71-01 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | HG6-64-1 | GDSC1 | 0.0200 | 5.1200 |
|
| LB647-SCLC | I-BET-762 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| LB647-SCLC | I-BET151 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | IAP_5620 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | IAP_7638 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | Ibrutinib | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | IC-87114 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | ICL1100013 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | Idelalisib | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | IGFR_3801 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | Imatinib | GDSC1 | 0.0078 | 2.0000 |
|
| LB647-SCLC | IMD-0354 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | IOX2 | GDSC1,GDSC2 | 0.0004 | 0.5000 |
|
| LB647-SCLC | IPA-3 | GDSC1 | 0.1250 | 32.0000 |
|
| LB647-SCLC | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Irinotecan | GDSC2 | 0.0050 | 5.0000 |
|
| LB647-SCLC | Ispinesib Mesylate | GDSC1 | 0.0005 | 0.1280 |
|
| LB647-SCLC | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| LB647-SCLC | JAK1_3715 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | JAK3_7406 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | JNJ38877605 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | JNK Inhibitor VIII | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | JNK-9L | GDSC1 | 0.0200 | 5.1200 |
|
| LB647-SCLC | JQ1 | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| LB647-SCLC | JQ12 | GDSC1 | 0.0200 | 5.1200 |
|
| LB647-SCLC | JW-7-52-1 | GDSC1 | 0.0047 | 1.2000 |
|
| LB647-SCLC | kb NB 142-70 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | KIN001-042 | GDSC1 | 0.0400 | 10.2400 |
|
| LB647-SCLC | Kobe2602 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| LB647-SCLC | KU-55933 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | KU-60019 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | Lapatinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LB647-SCLC | LCL161 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | LDN-193189 | GDSC1 | 0.0400 | 10.2400 |
|
| LB647-SCLC | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| LB647-SCLC | Lenalidomide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Lestaurtinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LB647-SCLC | LFM-A13 | GDSC1 | 0.0625 | 16.0000 |
|
| LB647-SCLC | LGK974 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | LIMK1 inhibitor BMS4 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | Linsitinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Luminespib | GDSC1,GDSC2 | 0.0003 | 0.2560 |
|
| LB647-SCLC | LY2109761 | GDSC2 | 0.0050 | 5.0000 |
|
| LB647-SCLC | MCT1_6447 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | MCT4_1422 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | MetAP2 Inhibitor, A832234 | GDSC1 | 0.0100 | 2.5600 |
|
| LB647-SCLC | Methotrexate | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| LB647-SCLC | MG-132 | GDSC1,GDSC2 | 0.0039 | 4.0000 |
|
| LB647-SCLC | Midostaurin | GDSC1 | 0.0020 | 0.5120 |
|
| LB647-SCLC | MIM1 | GDSC1 | 0.1562 | 40.0000 |
|
| LB647-SCLC | MIRA-1 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Mirin | GDSC2 | 0.1001 | 100.0000 |
|
| LB647-SCLC | Mitomycin-C | GDSC1 | 0.0625 | 16.0000 |
|
| LB647-SCLC | MK-1775 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | MK-2206 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| LB647-SCLC | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| LB647-SCLC | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Motesanib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LB647-SCLC | N22899-6-C1 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | N23918-95-7 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | N24798-49-A1 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | Navitoclax | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LB647-SCLC | NG-25 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | Nilotinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LB647-SCLC | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | NSC-207895 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | NSC-87877 | GDSC1 | 0.0625 | 16.0000 |
|
| LB647-SCLC | NSC319726 | GDSC1 | 0.0010 | 0.2560 |
|
| LB647-SCLC | NU7441 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LB647-SCLC | Nutlin-3a | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | NVP-ADW742 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | NVP-TAE684 | GDSC1 | 0.0078 | 2.0000 |
|
| LB647-SCLC | Obatoclax Mesylate | GDSC1 | 0.0625 | 16.0000 |
|
| LB647-SCLC | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Olaparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | OSI-027 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| LB647-SCLC | OSU-03012 | GDSC1 | 0.0625 | 16.0000 |
|
| LB647-SCLC | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Oxaliplatin | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | PAC-1 | GDSC1 | 0.0100 | 2.5600 |
|
| LB647-SCLC | Paclitaxel | GDSC1,GDSC2 | 0.0001 | 0.1024 |
|
| LB647-SCLC | Palbociclib | GDSC1,GDSC2 | 0.0040 | 4.0000 |
|
| LB647-SCLC | Panobinostat | GDSC1 | 0.0040 | 1.0240 |
|
| LB647-SCLC | PARP_0108 | GDSC1 | 0.0098 | 2.5000 |
|
| LB647-SCLC | PARP_9482 | GDSC1 | 0.0098 | 2.5000 |
|
| LB647-SCLC | PARP_9495 | GDSC1 | 0.0098 | 2.5000 |
|
| LB647-SCLC | Parthenolide | GDSC1 | 0.0195 | 5.0000 |
|
| LB647-SCLC | Pazopanib | GDSC1 | 0.0312 | 8.0000 |
|
| LB647-SCLC | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | PD0325901 | GDSC1,GDSC2 | 0.0010 | 2.5000 |
|
| LB647-SCLC | PD173074 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LB647-SCLC | Pemetrexed | GDSC1 | 0.0100 | 2.5600 |
|
| LB647-SCLC | Pevonedistat | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | PF-00299804 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | PF-4708671 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | PF-562271 | GDSC1 | 0.0100 | 2.5600 |
|
| LB647-SCLC | PFI-1 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | PFI3 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | PHA-665752 | GDSC1 | 0.0078 | 2.0000 |
|
| LB647-SCLC | Phenformin | GDSC1 | 15.6250 | 4000.0000 |
|
| LB647-SCLC | PI3Ka_4409 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Pictilisib | GDSC1,GDSC2 | 0.0040 | 4.0000 |
|
| LB647-SCLC | Pilaralisib | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | Piperlongumine | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | PLK_6522 | GDSC1 | 0.0024 | 0.6250 |
|
| LB647-SCLC | PLX-4720 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Ponatinib | GDSC1 | 0.0020 | 0.5120 |
|
| LB647-SCLC | PRIMA-1MET | GDSC2 | 0.0300 | 30.0000 |
|
| LB647-SCLC | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Pyrimethamine | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | QL-VIII-58 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | QL-XII-47 | GDSC1 | 0.0391 | 10.2400 |
|
| LB647-SCLC | QL-XII-61 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | QS11 | GDSC1 | 0.0400 | 10.2400 |
|
| LB647-SCLC | RAF_9304 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | Rapamycin | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| LB647-SCLC | Refametinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| LB647-SCLC | RO-3306 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | rTRAIL | GDSC1 | 0.0004 | 0.1000 |
|
| LB647-SCLC | RU-SKI 43 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | Rucaparib | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| LB647-SCLC | Ruxolitinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | S-Trityl-L-cysteine | GDSC1 | 0.0200 | 5.1200 |
|
| LB647-SCLC | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Salubrinal | GDSC1 | 0.0625 | 16.0000 |
|
| LB647-SCLC | Sapitinib | GDSC2 | 0.0050 | 5.0000 |
|
| LB647-SCLC | Saracatinib | GDSC1 | 0.0078 | 2.0000 |
|
| LB647-SCLC | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| LB647-SCLC | SB216763 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | SB505124 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| LB647-SCLC | SB590885 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| LB647-SCLC | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| LB647-SCLC | Seliciclib | GDSC1 | 0.0625 | 16.0000 |
|
| LB647-SCLC | Selisistat | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | Selumetinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Sepantronium bromide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Serdemetan | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | SGC0946 | GDSC1,GDSC2 | 0.0005 | 0.5000 |
|
| LB647-SCLC | Shikonin | GDSC1 | 0.0625 | 16.0000 |
|
| LB647-SCLC | SL0101 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | SN-38 | GDSC1,GDSC2 | 0.0002 | 10.0000 |
|
| LB647-SCLC | Sorafenib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Sphingosine Kinase 1 Inhibitor II | GDSC1 | 0.0100 | 2.5600 |
|
| LB647-SCLC | Staurosporine | GDSC2 | 0.0078 | 2.0000 |
|
| LB647-SCLC | STF-62247 | GDSC1 | 0.0400 | 10.2400 |
|
| LB647-SCLC | SU11274 | GDSC1 | 0.0400 | 10.2400 |
|
| LB647-SCLC | Sunitinib | GDSC1 | 0.0312 | 8.0000 |
|
| LB647-SCLC | TAK-715 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | Talazoparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Tamoxifen | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Tanespimycin | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| LB647-SCLC | TANK_1366 | GDSC1 | 0.0098 | 2.5000 |
|
| LB647-SCLC | Taselisib | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Telomerase Inhibitor IX | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Temozolomide | GDSC1,GDSC2 | 0.0300 | 30.0000 |
|
| LB647-SCLC | Temsirolimus | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| LB647-SCLC | Tenovin-6 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | TGX221 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | Thapsigargin | GDSC1 | 0.0020 | 0.5120 |
|
| LB647-SCLC | THZ-1-87 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | THZ-2-98-01 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | Tipifarnib | GDSC1 | 0.0625 | 16.0000 |
|
| LB647-SCLC | TL-2-105 | GDSC1 | 0.0400 | 10.2400 |
|
| LB647-SCLC | Torin 2 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | torin2 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | Tozasertib | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| LB647-SCLC | Trametinib | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| LB647-SCLC | Tretinoin | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Trichostatin A | GDSC1 | 0.0040 | 1.0240 |
|
| LB647-SCLC | TTK_3146 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | Tubastatin A | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | TW 37 | GDSC1 | 0.0195 | 5.0000 |
|
| LB647-SCLC | TWS119 | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | Ulixertinib | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | UNC0638 | GDSC1 | 0.0781 | 40.0000 |
|
| LB647-SCLC | UNC0642 | GDSC1 | 0.0020 | 0.5000 |
|
| LB647-SCLC | UNC1215 | GDSC1 | 0.0039 | 1.0000 |
|
| LB647-SCLC | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| LB647-SCLC | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Veliparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Venetoclax | GDSC2 | 0.0010 | 1.0000 |
|
| LB647-SCLC | Venotoclax | GDSC1 | 0.0010 | 0.2560 |
|
| LB647-SCLC | Vinblastine | GDSC1 | 0.0004 | 0.1000 |
|
| LB647-SCLC | Vinorelbine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| LB647-SCLC | Vismodegib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | VNLG-124 | GDSC1 | 0.0200 | 5.1200 |
|
| LB647-SCLC | Vorinostat | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Voxtalisib | GDSC1 | 0.0781 | 20.0000 |
|
| LB647-SCLC | VX-11e | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | VX-702 | GDSC1 | 0.0078 | 2.0000 |
|
| LB647-SCLC | Wee1 Inhibitor | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LB647-SCLC | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | WH-4-023 | GDSC1 | 0.0200 | 5.1200 |
|
| LB647-SCLC | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Wnt-C59 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | WYE-125132 | GDSC1 | 0.0400 | 10.2400 |
|
| LB647-SCLC | WZ-1-84 | GDSC1 | 0.0400 | 10.2400 |
|
| LB647-SCLC | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | XAV939 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| LB647-SCLC | XMD11-50 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | XMD11-85h | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | XMD8-85 | GDSC1 | 0.0312 | 8.0000 |
|
| LB647-SCLC | XMD8-92 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | YK-4-279 | GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | Z-LLNle-CHO | GDSC1 | 0.0100 | 2.5600 |
|
| LB647-SCLC | ZG-10 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | ZL049 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | ZL109 | GDSC1 | 0.0391 | 10.0000 |
|
| LB647-SCLC | ZM447439 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LB647-SCLC | ZSTK474 | GDSC1 | 0.0200 | 5.1200 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC